Mousavi-Kiasary, S.M.S.; Senabreh, A.; Zandi, A.; Pena, R.; Cruz, F.; Adibi, A.; Hooshmand, N.
Synergistic Cancer Therapies Enhanced by Nanoparticles: Advancing Nanomedicine Through Multimodal Strategies. Pharmaceutics 2025, 17, 682.
https://doi.org/10.3390/pharmaceutics17060682
AMA Style
Mousavi-Kiasary SMS, Senabreh A, Zandi A, Pena R, Cruz F, Adibi A, Hooshmand N.
Synergistic Cancer Therapies Enhanced by Nanoparticles: Advancing Nanomedicine Through Multimodal Strategies. Pharmaceutics. 2025; 17(6):682.
https://doi.org/10.3390/pharmaceutics17060682
Chicago/Turabian Style
Mousavi-Kiasary, Seyed Mohamad Sadegh, Ahmood Senabreh, Ashkan Zandi, Rogelio Pena, Frances Cruz, Ali Adibi, and Nasrin Hooshmand.
2025. "Synergistic Cancer Therapies Enhanced by Nanoparticles: Advancing Nanomedicine Through Multimodal Strategies" Pharmaceutics 17, no. 6: 682.
https://doi.org/10.3390/pharmaceutics17060682
APA Style
Mousavi-Kiasary, S. M. S., Senabreh, A., Zandi, A., Pena, R., Cruz, F., Adibi, A., & Hooshmand, N.
(2025). Synergistic Cancer Therapies Enhanced by Nanoparticles: Advancing Nanomedicine Through Multimodal Strategies. Pharmaceutics, 17(6), 682.
https://doi.org/10.3390/pharmaceutics17060682
